SCHEMBL8285359

SCHEMBL8285359

Cc1cc2c(c(NC(=O)Nc3ccccc3)n1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.47
CYP1A2 P05177 1/20 0.47
TSHR P16473 1/20 0.46
KCNJ6 P48051 1/20 0.46
KCNJ5 P48544 1/20 0.46
KCNJ3 P48549 1/20 0.46
SLC2A1 P11166 1/20 0.43
ADORA3 P0DMS8 2/20 0.41
ATM Q13315 2/20 0.40
MAPK13 O15264 4/20 0.39
MAPK12 P53778 4/20 0.39
MAPK11 Q15759 4/20 0.39
MAPK14 Q16539 4/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
LMNA P02545 1/20 0.39
MEN1 O00255 1/20 0.39
GBA1 P04062 1/20 0.39
KMT2A Q03164 1/20 0.39
NTRK1 P04629 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285358 0.89 GAA (0.43) KDM4EADORA3NPC1RAB9ALMNA
SCHEMBL8287944 0.88 GAA (0.43) KDM4ECYP1A2TSHRATMNPC1
SCHEMBL8286535 0.86 OPRK1 (0.45) TSHRKCNJ6KCNJ5KCNJ3SLC2A1
SCHEMBL8358804 0.84 MAT2A (0.41) KDM4ETSHRKCNJ6KCNJ5KCNJ3
SCHEMBL8287217 0.84 RIPK1 (0.43) KDM4ETSHRKCNJ6KCNJ5KCNJ3
SCHEMBL5871645 0.83 GAA (0.42) KDM4ECYP1A2TSHRKCNJ6KCNJ5
SCHEMBL8286573 0.82 GAA (0.42) KDM4ECYP1A2TSHRATMNPC1
SCHEMBL5872108 0.82 GAA (0.44) KDM4ECYP1A2TSHRATMNPC1
SCHEMBL5872094 0.82 PDE11A (0.40) KDM4ECYP1A2TSHRKCNJ6KCNJ5
SCHEMBL8285272 0.82 PDE11A (0.37) KDM4ETSHRNPC1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed